---
title: "Allogene Therapeutics, Inc. (ALLO.US) — 公司概況"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ALLO.US/overview.md"
symbol: "ALLO.US"
name: "Allogene Therapeutics, Inc."
parent: "https://longbridge.com/zh-HK/quote/ALLO.US.md"
datetime: "2026-04-15T09:32:10.646Z"
locales:
  - [en](https://longbridge.com/en/quote/ALLO.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALLO.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALLO.US/overview.md)
---

# Allogene Therapeutics, Inc. (ALLO.US) — 公司概況

## 基本資訊

| 項目 | 詳情 |
|------|--------|
| 行業 | 生物技術 |
| 交易所 | US Market |
| 地址 | 210 East Grand Avenue, South San Francisco, California, United States |
| 官網 | [allogene.com](https://allogene.com) |

## 公司簡介

Allogene Therapeutics, Inc.是一家臨床階段的免疫腫瘤學公司，開發和商業化基因工程異體 T 細胞療法，用于治療癌症和自身免疫疾病。該公司開發了一系列多種異體 CAR T 細胞產品候選藥物，利用蛋白質工程、基因編輯、基因插入和先進的專有 T 細胞制造技術。該公司還在開發 cemacabtagene ansegedleucel（cema-cel），這是一種針對 CD19 的工程異體 CAR T 細胞產品候選藥物，用于治療大 B 細胞淋巴瘤（LBCL）

## 核心管理層

| 名稱 | 職位 |
|------|-------|
| Arie S. Belldegrun | Co-Founder & Executive Chairman |
| David D. Chang | Co-Founder, President, CEO & Director |
| Joshua A. Kazam | Co-Founder & Director |
| Zachary J. Roberts | Executive VP of Research & Development and Chief Medical Officer |
| Geoffrey M. Parker | Executive VP & CFO |
| Franz Bernhard Humer | Lead Independent Director |
| Owen N. Witte | Independent Director |

## 主要股東

| 名稱 | 佔比 | 報告日期 |
|------|-------|-------------|
| Pfizer Venture Investments LLC | 9.04% | 2025-12-31 |
| TPG Capital, L.P. | 7.68% | 2025-12-31 |
| BlackRock, Inc. | 7.25% | 2025-12-31 |
| Citadel Advisors LLC | 4.97% | 2025-12-31 |
| The Vanguard Group, Inc. | 3.80% | 2025-12-31 |
| PRIMECAP Management Company | 3.34% | 2025-12-31 |
| David D. Chang | 2.44% | 2026-03-16 |
| Arie S. Belldegrun | 2.40% | 2026-02-02 |
| Patient Square Capital, LP | 2.04% | 2025-12-31 |
| Geode Capital Management, LLC | 1.61% | 2025-12-31 |

## 業務構成

| 業務線 | 營收 | 佔比 |
|---------|---------|-------|
| 藥品 | 22000 | 100% |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "Allogene Therapeutics, Inc. Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "藥品",
        "ratio": 100
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```

## 地區分佈

| 地區 | 營收 | 佔比 |
|--------|---------|-------|
| 美國 | 22000 | 100% |


---

> **免責聲明: 本文僅供參考，不構成任何投資建議。**